Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine

More effective rotavirus vaccines are essential for preventing extensive diarrheal morbidity and mortality in children under five years of age in low-resource regions. Nonreplicating rotavirus vaccines (NRRV) administered parenterally provide an alternate vaccination method to the current licensed o...

Descripció completa

Dades bibliogràfiques

Autors principals:	Kyle Lakatos, David McAdams, Jessica A. White, Dexiang Chen
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2020-08-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	rotavirus nonreplicating rotavirus vaccine (nrrv) antigen adsorption antigen integrity immunogenicity
Accés en línia:	http://dx.doi.org/10.1080/21645515.2019.1710412
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!